Literature DB >> 11120930

Invasive pneumococcal disease in England and Wales: vaccination implications.

K Sleeman1, K Knox, R George, E Miller, P Waight, D Griffiths, A Efstratiou, K Broughton, R T Mayon-White, E R Moxon, D W Crook.   

Abstract

Knowledge of the epidemiology of invasive pneumococcal disease (IPD) will aid in planning the use of pneumococcal vaccines. A United Kingdom (UK)-based surveillance in England and Wales (1995-1997) of 11,528 individuals with IPD and a local enhanced surveillance in the Oxford (UK) area (1995-1999) have been analyzed. IPD has a high attack rate in children, with 37.1-48.1 cases per 100,000 infants <1 year old per year, and in older persons, with 21.2-36.2 cases per 100,000 persons >65 years old per year, for England, Wales, and Oxford. The 7-valent conjugate vaccine includes serotypes causing < or =79% of IPD in children <5 years old, but only 66% in adults >65 years old. The data also indicate that IPD varies by serotype, age, and country, emphasizing that the epidemiology of IPD is heterogeneous and requires continued surveillance.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11120930     DOI: 10.1086/317924

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  32 in total

Review 1.  New pneumococcal vaccines for children.

Authors:  S Choo; A Finn
Journal:  Arch Dis Child       Date:  2001-04       Impact factor: 3.791

2.  Geographic distribution and clonal diversity of Streptococcus pneumoniae serotype 1 isolates.

Authors:  Angela B Brueggemann; Brian G Spratt
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

Review 3.  Pneumococcal vaccine and patients with pulmonary diseases.

Authors:  Mehdi Mirsaeidi; Golnaz Ebrahimi; Mary Beth Allen; Stefano Aliberti
Journal:  Am J Med       Date:  2014-05-20       Impact factor: 4.965

4.  Diagnosis of invasive pneumococcal infection by serotype-specific urinary antigen detection.

Authors:  John P Leeming; Keith Cartwright; Rhonwen Morris; Siobhan A Martin; Michael D Smith
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

Review 5.  Use and clinical interpretation of pneumococcal antibody measurements in the evaluation of humoral immune function.

Authors:  Thomas M Daly; Harry R Hill
Journal:  Clin Vaccine Immunol       Date:  2014-12-17

6.  Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries.

Authors:  S M A A Evers; A J H A Ament; G L Colombo; H B Konradsen; R R Reinert; D Sauerland; K Wittrup-Jensen; C Loiseau; D S Fedson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-08       Impact factor: 3.267

7.  Nasopharyngeal carriage of Streptococcus pneumoniae in healthy children: implications for the use of heptavalent pneumococcal conjugate vaccine.

Authors:  Paola Marchisio; Susanna Esposito; Gian Carlo Schito; Anna Marchese; Roberta Cavagna; Nicola Principi
Journal:  Emerg Infect Dis       Date:  2002-05       Impact factor: 6.883

8.  Immune response to the 7-valent pneumococcal conjugate vaccine in 30 asplenic children.

Authors:  B Mikoluc; H Kayhty; E Bernatowska; R Motkowski
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-06-27       Impact factor: 3.267

9.  How many episodes of hospital care might be prevented by widespread uptake of pneumococcal conjugate vaccine?

Authors:  E D G McIntosh
Journal:  Arch Dis Child       Date:  2003-10       Impact factor: 3.791

10.  Implications of Streptococcus pneumoniae penicillin resistance and serotype distribution in Kuwait for disease treatment and prevention.

Authors:  Eiman M Mokaddas; Vincent O Rotimi; M John Albert
Journal:  Clin Vaccine Immunol       Date:  2007-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.